TTD | Drug: D0X7PP

Drug General Information
Drug ID	D0X7PP
Former ID	DNC014319
Drug Name	ERITADENINE
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530323]
Structure		Download 2D MOL 3D MOL
Formula	C9H11N5O4
Canonical SMILES	C1=NC2=C(C(=N1)N)N=CN2CC(C(C(=O)O)O)O
InChI	1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1
InChIKey	LIEMBEWXEZJEEZ-INEUFUBQSA-N
PubChem Compound ID	159961
Target and Pathway
Target(s)	Adenosylhomocysteinase	Target Info	Inhibitor	[530323]
BioCyc Pathway	Superpathway of methionine degradation
	Methionine degradation
	Cysteine biosynthesis
KEGG Pathway	Cysteine and methionine metabolism
KEGG Pathway	Metabolic pathways
PathWhiz Pathway	Selenoamino Acid Metabolism
	Betaine Metabolism
	Methionine Metabolism
WikiPathways	Metabolism of amino acids and derivatives
	Trans-sulfuration and one carbon metabolism
	One Carbon Metabolism
	Trans-sulfuration pathway
	Phase II conjugation
	Folate Metabolism
References
Ref 530323	Bioorg Med Chem. 2009 Sep 15;17(18):6707-14. Epub 2009 Jul 28.A new structural class of S-adenosylhomocysteine hydrolase inhibitors.
Ref 530323	Bioorg Med Chem. 2009 Sep 15;17(18):6707-14. Epub 2009 Jul 28.A new structural class of S-adenosylhomocysteine hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information